BusinessCytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA ConferenceBy Nasdaq OMXApr 24, 2018, 11:30 AM UTC
BusinessAxsome Therapeutics Hosts R&D Day Today with Key Opinion Leaders Focusing on AXS-05 and Unmet Needs in Depression, Alzheimer’s Disease Agitation, and Nicotine DependenceBy Nasdaq OMXApr 24, 2018, 11:01 AM UTC
BusinessAxsome Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of AXS-05 in Smoking CessationBy Nasdaq OMXApr 23, 2018, 11:00 AM UTC
BusinessProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVOBy Nasdaq OMXApr 23, 2018, 11:00 AM UTC
BusinessNewLink Genetics to Host Its First Quarter 2018 Financial Results Conference Call on May 3, 2018By Nasdaq OMXApr 20, 2018, 1:00 PM UTC
BusinessAbeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten DiseaseBy Nasdaq OMXApr 20, 2018, 12:15 PM UTC
BusinessNetworkNewsAudio Covers Lexaria’s Biotech Breakthrough in Nicotine DeliveryBy Nasdaq OMXApr 20, 2018, 10:00 AM UTC
